Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesUrologyBaylor Scott & White — Nerve Graft Coverage | Open…
    Ask Trek AI about this page
    CurrentBaylor Scott & White Health PlanPolicy 060

    Nerve Graft with Radical Prostatectomy

    Customize your policy alerts

    Sign up for Baylor Scott & White Health Plan Policy 060 alerts

    Get alerted when Policy 060 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs prior authorization and coverage determinations for unilateral or bilateral nerve grafting performed with radical prostatectomy for erectile dysfunction, and applies to Baylor Scott & White Health Plan members unless superseded by plan documents or applicable Medicare/Medicaid mandates.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyNerve Graft with Radical Prostatectomy
    Policy CodePolicy 060
    Change TypeNo material change
    Effective DateJun 1, 2026
    Last ReviewMay 28, 2026
    Next Review DateMay 28, 2027
    Key ActionSubmit prior authorization with clinical rationale and supporting literature for nerve graft procedures associated with radical prostatectomy.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    PA requiredauthorization requirement

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Experimentalcoverage stance
    Codes not coveredcoding exclusions
    12+references

    Coverage Determinations

    Experimental/Investigational

    Covered when ALL of the following are met:

    Primary coverage determination: BSWHP considers unilateral or bilateral nerve graft experimental and investigational in patients with erectile dysfunction who have undergone resection of one or both neurovascular bundles as part of radical prostatectomy because there is a paucity of peer-reviewed literature demonstrating efficacy.

    Includes sural nerve grafts and other nerve grafts applied at time of prostatectomy.

    Conservative alternatives

    Context and alternatives

    Alternatives: Noninvasive treatments such as vacuum constriction devices and intracavernosal injections are available; spontaneous erections are preferred but often absent after bilateral neurovascular bundle resection.

    Documentation of prior conservative therapy may be considered in evaluations.

    The following procedure and supply codes are identified in the policy as not covered when billed for nerve grafting in association with radical prostatectomy: CPT codes 64910, 64911, 64912, 64913, 64999, and HCPCS codes C9352, C9353, C9355, C9361. Example diagnosis codes called out in the policy include ICD-10 codes N52.01 (male erectile dysfunction following radical retro-pubic prostatectomy) and N52.9 (male erectile dysfunction).

    BSWHP considers unilateral or bilateral nerve grafting performed at the time of radical prostatectomy to be experimental/investigational and not medically necessary because there is a paucity of peer‑reviewed literature demonstrating efficacy. This stance includes sural nerve grafts and other nerve graft techniques and applies to adjunctive collagen nerve grafts/wraps (for example, Avance®, Axogen 2 Nerve Wrap, Integra NeuralWrap™, and various collagen nerve cuff/wraps), which the policy identifies as unproven for all indications.

    CPT, HCPCS, and ICD-10 Coding

    CPT Not CoveredCPTNot Covered
    64910
    64911
    64912
    64913
    64999
    HCPCS Not CoveredHCPCSNot Covered
    C9352Microporous collagen implantable tube (NeuraGen Nerve Guide)
    C9353Microporous collagen implantable slit tube (NeuraWrap Nerve Protector)
    C9355Collagen nerve cuff (NeuroMatrix)
    C9361Collagen matrix nerve wrap (NeuroMend Collagen Nerve Wrap)
    ICD-10 Not Covered (examples listed)ICD-10Not Covered
    N52.01Male erectile dysfunction following radical retro-pubic prostatectomy
    N52.9Male erectile dysfunction

    Prior Authorization & Provider Requirements

    Prior Authorization

    Prior authorization required for nerve graft with radical prostatectomy

    Prior authorization is required for nerve graft procedures performed in association with radical prostatectomy; several CPT and HCPCS codes related to these procedures are listed in the policy and should be addressed in PA submissions.

    • Policy header: PRIOR AUTHORIZATION: Required
    • PA applies to nerve graft in association with radical prostatectomy and to listed CPT/HCPCS codes
    Step Therapy

    Document conservative, noninvasive alternatives first

    Noninvasive conservative treatments are available and are described as alternatives to nerve grafting; document use of these options when relevant to medical necessity evaluations.

    • Vacuum constriction devices
    • Intracavernosal (intra-cavernosal) injection therapy

    Clinical Background

    Erectile dysfunction is a common sequela of radical prostatectomy, particularly when one or both neurovascular bundles are resected. Surgical approaches such as sural nerve grafting—harvesting a segment of the sural nerve and anastomosing it to divided cavernous nerve ends—have been attempted to restore erectile function, and a variety of nerve wraps and graft materials have been described. However, available data on long‑term outcomes are limited and insufficient to demonstrate effectiveness, which underpins the policy’s noncoverage determination and coding exclusions.

    Definitions

    Sural nerve graft — definition and description of procedure
    DefinitionHarvesting a portion of the sural nerve from the leg and anastomosing it to the divided ends of the cavernous nerve during radical prostatectomy to attempt restoration of erectile function.
    Anatomic sourceSural nerve (harvested from one leg); other donor nerves (e.g., genitofemoral) have also been reported.
    Procedure steps (concise)Harvest donor sural nerve segment, prepare and align graft, microsurgical anastomosis to the divided cavernous nerve ends during prostatectomy.
    Intended goalAttempt restoration of cavernous nerve function and erectile function after neurovascular bundle resection during radical prostatectomy.
    Evidence summaryLimited data and insufficient long-term outcome evidence to support effectiveness of sural nerve grafting in men undergoing prostatectomy.
    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyNerve Graft with Radical Prostatectomy
    Policy CodePolicy 060
    Change TypeNo material change
    Effective DateJun 1, 2026
    Last ReviewMay 28, 2026
    Next Review DateMay 28, 2027
    Key ActionSubmit prior authorization with clinical rationale and supporting literature for nerve graft procedures associated with radical prostatectomy.
    SourceLink
    On This Page
    Coverage DeterminationsCPT, HCPCS, and ICD-10 CodingPrior Authorization & Provider RequirementsClinical BackgroundDefinitions
  1. Note: spontaneous erectile activity is preferred by patients; documentation of prior conservative therapy may be considered
  2. Documentation Required

    Include clinical rationale and supporting literature with PA request

    Submit a prior authorization request per plan procedures and include the clinical rationale and any supporting literature or evidence to justify the procedure; refer to applicable plan EOC/SPD and Medicare/Medicaid guidance where relevant.

    • Include clinical rationale describing why conservative alternatives are insufficient if applicable
    • Attach peer‑reviewed literature or evidence supporting surgical nerve grafting when available
    Denial Risk

    Denial risk: procedure considered experimental/investigational

    Nerve grafting (unilateral or bilateral) for erectile dysfunction after radical prostatectomy is considered experimental/investigational; claims for these services are at risk of denial for medical necessity.

    • Policy states BSWHP considers unilateral or bilateral nerve graft experimental and investigational due to limited peer‑reviewed evidence
    • Includes sural nerve grafts and other nerve grafts applied at time of prostatectomy
    Billing Rule

    Coding-based denial risk: listed CPT/HCPCS/ICD‑10 codes not covered

    Specified CPT, HCPCS, and example ICD‑10 diagnosis codes are listed as not covered in the policy and may lead to claim denial if billed for these services.

    • CPT codes listed as not covered: 64910, 64911, 64912, 64913, 64999
    • HCPCS codes listed as not covered: C9352, C9353, C9355, C9361
    • ICD‑10 examples listed as not covered: N52.01, N52.9